✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Iovance Biotherapeutics Inc

Common Name
Iovance Biotherapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
975
Ticker
IOVA
Exchange
NASDAQ/NMS
Description
Iovance Biotherapeutics is a commercial-stage biopharmaceutical company pioneering the development and commercialization of tumor-infiltrating lymphocyte (TIL) cell therapies for patients with solid t...

Iovance Biotherapeutics's Board and Committee Meetings Data

Explore Iovance Biotherapeutics's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2025
Board Meeting Count
3a
Audit Committee Meeting Count
4a
Compensation/Remuneration Committee Meeting Count
2a
Nomination Committee Meeting Count
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Iovance Biotherapeutics’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Iovance Biotherapeutics's DEF 14A 2025